Table of Content

1 Pandemic Influenza Vaccine Market Overview
1.1 Product Overview and Scope of Pandemic Influenza Vaccine
1.2 Pandemic Influenza Vaccine Segment by Type
1.2.1 Global Pandemic Influenza Vaccine Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Whole Virus Vaccines
1.2.3 Split Virus Vaccines
1.2.4 Subunit Vaccines
1.3 Pandemic Influenza Vaccine Segment by Application
1.3.1 Global Pandemic Influenza Vaccine Sales Comparison by Application: (2021-2027)
1.3.2 For Children (6 months to 3 years)
1.3.3 For Adults and Children over 3 years
1.4 Global Pandemic Influenza Vaccine Market Size Estimates and Forecasts
1.4.1 Global Pandemic Influenza Vaccine Revenue 2016-2027
1.4.2 Global Pandemic Influenza Vaccine Sales 2016-2027
1.4.3 Pandemic Influenza Vaccine Market Size by Region: 2016 Versus 2021 Versus 2027

2 Pandemic Influenza Vaccine Market Competition by Manufacturers
2.1 Global Pandemic Influenza Vaccine Sales Market Share by Manufacturers (2016-2021)
2.2 Global Pandemic Influenza Vaccine Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Pandemic Influenza Vaccine Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Pandemic Influenza Vaccine Manufacturing Sites, Area Served, Product Type
2.5 Pandemic Influenza Vaccine Market Competitive Situation and Trends
2.5.1 Pandemic Influenza Vaccine Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Pandemic Influenza Vaccine Players Market Share by Revenue
2.5.3 Global Pandemic Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Pandemic Influenza Vaccine Retrospective Market Scenario by Region
3.1 Global Pandemic Influenza Vaccine Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Pandemic Influenza Vaccine Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Pandemic Influenza Vaccine Market Facts & Figures by Country
3.3.1 North America Pandemic Influenza Vaccine Sales by Country
3.3.2 North America Pandemic Influenza Vaccine Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Pandemic Influenza Vaccine Market Facts & Figures by Country
3.4.1 Europe Pandemic Influenza Vaccine Sales by Country
3.4.2 Europe Pandemic Influenza Vaccine Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Pandemic Influenza Vaccine Market Facts & Figures by Region
3.5.1 Asia Pacific Pandemic Influenza Vaccine Sales by Region
3.5.2 Asia Pacific Pandemic Influenza Vaccine Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Pandemic Influenza Vaccine Market Facts & Figures by Country
3.6.1 Latin America Pandemic Influenza Vaccine Sales by Country
3.6.2 Latin America Pandemic Influenza Vaccine Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Pandemic Influenza Vaccine Market Facts & Figures by Country
3.7.1 Middle East and Africa Pandemic Influenza Vaccine Sales by Country
3.7.2 Middle East and Africa Pandemic Influenza Vaccine Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Pandemic Influenza Vaccine Historic Market Analysis by Type
4.1 Global Pandemic Influenza Vaccine Sales Market Share by Type (2016-2021)
4.2 Global Pandemic Influenza Vaccine Revenue Market Share by Type (2016-2021)
4.3 Global Pandemic Influenza Vaccine Price by Type (2016-2021)

5 Global Pandemic Influenza Vaccine Historic Market Analysis by Application
5.1 Global Pandemic Influenza Vaccine Sales Market Share by Application (2016-2021)
5.2 Global Pandemic Influenza Vaccine Revenue Market Share by Application (2016-2021)
5.3 Global Pandemic Influenza Vaccine Price by Application (2016-2021)

6 Key Companies Profiled
6.1 CSL
6.1.1 CSL Corporation Information
6.1.2 CSL Description and Business Overview
6.1.3 CSL Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.1.4 CSL Pandemic Influenza Vaccine Product Portfolio
6.1.5 CSL Recent Developments/Updates
6.2 GSK
6.2.1 GSK Corporation Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.2.4 GSK Pandemic Influenza Vaccine Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Sanofi Pasteur
6.3.1 Sanofi Pasteur Corporation Information
6.3.2 Sanofi Pasteur Description and Business Overview
6.3.3 Sanofi Pasteur Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Sanofi Pasteur Pandemic Influenza Vaccine Product Portfolio
6.3.5 Sanofi Pasteur Recent Developments/Updates
6.4 Mylan
6.4.1 Mylan Corporation Information
6.4.2 Mylan Description and Business Overview
6.4.3 Mylan Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Mylan Pandemic Influenza Vaccine Product Portfolio
6.4.5 Mylan Recent Developments/Updates
6.5 AstraZeneca
6.5.1 AstraZeneca Corporation Information
6.5.2 AstraZeneca Description and Business Overview
6.5.3 AstraZeneca Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.5.4 AstraZeneca Pandemic Influenza Vaccine Product Portfolio
6.5.5 AstraZeneca Recent Developments/Updates
6.6 Pfizer
6.6.1 Pfizer Corporation Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Pfizer Pandemic Influenza Vaccine Product Portfolio
6.6.5 Pfizer Recent Developments/Updates
6.7 Johnson & Johnson
6.6.1 Johnson & Johnson Corporation Information
6.6.2 Johnson & Johnson Description and Business Overview
6.6.3 Johnson & Johnson Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Johnson & Johnson Pandemic Influenza Vaccine Product Portfolio
6.7.5 Johnson & Johnson Recent Developments/Updates

7 Pandemic Influenza Vaccine Manufacturing Cost Analysis
7.1 Pandemic Influenza Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Pandemic Influenza Vaccine
7.4 Pandemic Influenza Vaccine Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Pandemic Influenza Vaccine Distributors List
8.3 Pandemic Influenza Vaccine Customers

9 Pandemic Influenza Vaccine Market Dynamics
9.1 Pandemic Influenza Vaccine Industry Trends
9.2 Pandemic Influenza Vaccine Growth Drivers
9.3 Pandemic Influenza Vaccine Market Challenges
9.4 Pandemic Influenza Vaccine Market Restraints

10 Global Market Forecast
10.1 Pandemic Influenza Vaccine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Pandemic Influenza Vaccine by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Pandemic Influenza Vaccine by Type (2022-2027)
10.2 Pandemic Influenza Vaccine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Pandemic Influenza Vaccine by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Pandemic Influenza Vaccine by Application (2022-2027)
10.3 Pandemic Influenza Vaccine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Pandemic Influenza Vaccine by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Pandemic Influenza Vaccine by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Pandemic Influenza Vaccine Sales (K Doses) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Pandemic Influenza Vaccine Sales (K Doses) Comparison by Application (2021-2027)
Table 3. Global Pandemic Influenza Vaccine Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Pandemic Influenza Vaccine Covered in This Study
Table 5. Global Pandemic Influenza Vaccine Sales (K Doses) of Key Manufacturers (2016-2021)
Table 6. Global Pandemic Influenza Vaccine Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Pandemic Influenza Vaccine Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Pandemic Influenza Vaccine Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Pandemic Influenza Vaccine Average Price (USD/Dose) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Pandemic Influenza Vaccine Manufacturing Sites and Area Served
Table 11. Manufacturers Pandemic Influenza Vaccine Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Pandemic Influenza Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pandemic Influenza Vaccine as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Pandemic Influenza Vaccine Sales by Region (2016-2021) & (K Doses)
Table 16. Global Pandemic Influenza Vaccine Sales Market Share by Region (2016-2021)
Table 17. Global Pandemic Influenza Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Pandemic Influenza Vaccine Sales by Country (2016-2021) & (K Doses)
Table 19. North America Pandemic Influenza Vaccine Sales Market Share by Country (2016-2021)
Table 20. North America Pandemic Influenza Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Pandemic Influenza Vaccine Revenue Market Share by Country (2016-2021)
Table 22. Europe Pandemic Influenza Vaccine Sales by Country (2016-2021) & (K Doses)
Table 23. Europe Pandemic Influenza Vaccine Sales Market Share by Country (2016-2021)
Table 24. Europe Pandemic Influenza Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Pandemic Influenza Vaccine Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Pandemic Influenza Vaccine Sales by Region (2016-2021) & (K Doses)
Table 27. Asia Pacific Pandemic Influenza Vaccine Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Pandemic Influenza Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Pandemic Influenza Vaccine Revenue Market Share by Region (2016-2021)
Table 30. Latin America Pandemic Influenza Vaccine Sales by Country (2016-2021) & (K Doses)
Table 31. Latin America Pandemic Influenza Vaccine Sales Market Share by Country (2016-2021)
Table 32. Latin America Pandemic Influenza Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Pandemic Influenza Vaccine Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Pandemic Influenza Vaccine Sales by Country (2016-2021) & (K Doses)
Table 35. Middle East and Africa Pandemic Influenza Vaccine Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Pandemic Influenza Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Pandemic Influenza Vaccine Revenue Market Share by Country (2016-2021)
Table 38. Global Pandemic Influenza Vaccine Sales (K Doses) by Type (2016-2021)
Table 39. Global Pandemic Influenza Vaccine Sales Market Share by Type (2016-2021)
Table 40. Global Pandemic Influenza Vaccine Revenue (Million US$) by Type (2016-2021)
Table 41. Global Pandemic Influenza Vaccine Revenue Share by Type (2016-2021)
Table 42. Global Pandemic Influenza Vaccine Price (USD/Dose) by Type (2016-2021)
Table 43. Global Pandemic Influenza Vaccine Sales (K Doses) by Application (2016-2021)
Table 44. Global Pandemic Influenza Vaccine Sales Market Share by Application (2016-2021)
Table 45. Global Pandemic Influenza Vaccine Revenue (Million US$) by Application (2016-2021)
Table 46. Global Pandemic Influenza Vaccine Revenue Share by Application (2016-2021)
Table 47. Global Pandemic Influenza Vaccine Price (USD/Dose) by Application (2016-2021)
Table 48. CSL Corporation Information
Table 49. CSL Description and Business Overview
Table 50. CSL Pandemic Influenza Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 51. CSL Pandemic Influenza Vaccine Product
Table 52. CSL Recent Developments/Updates
Table 53. GSK Corporation Information
Table 54. GSK Description and Business Overview
Table 55. GSK Pandemic Influenza Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 56. GSK Pandemic Influenza Vaccine Product
Table 57. GSK Recent Developments/Updates
Table 58. Sanofi Pasteur Corporation Information
Table 59. Sanofi Pasteur Description and Business Overview
Table 60. Sanofi Pasteur Pandemic Influenza Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 61. Sanofi Pasteur Pandemic Influenza Vaccine Product
Table 62. Sanofi Pasteur Recent Developments/Updates
Table 63. Mylan Corporation Information
Table 64. Mylan Description and Business Overview
Table 65. Mylan Pandemic Influenza Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 66. Mylan Pandemic Influenza Vaccine Product
Table 67. Mylan Recent Developments/Updates
Table 68. AstraZeneca Corporation Information
Table 69. AstraZeneca Description and Business Overview
Table 70. AstraZeneca Pandemic Influenza Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 71. AstraZeneca Pandemic Influenza Vaccine Product
Table 72. AstraZeneca Recent Developments/Updates
Table 73. Pfizer Corporation Information
Table 74. Pfizer Description and Business Overview
Table 75. Pfizer Pandemic Influenza Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 76. Pfizer Pandemic Influenza Vaccine Product
Table 77. Pfizer Recent Developments/Updates
Table 78. Johnson & Johnson Corporation Information
Table 79. Johnson & Johnson Description and Business Overview
Table 80. Johnson & Johnson Pandemic Influenza Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 81. Johnson & Johnson Pandemic Influenza Vaccine Product
Table 82. Johnson & Johnson Recent Developments/Updates
Table 83. Production Base and Market Concentration Rate of Raw Material
Table 84. Key Suppliers of Raw Materials
Table 85. Pandemic Influenza Vaccine Distributors List
Table 86. Pandemic Influenza Vaccine Customers List
Table 87. Pandemic Influenza Vaccine Market Trends
Table 88. Pandemic Influenza Vaccine Growth Drivers
Table 89. Pandemic Influenza Vaccine Market Challenges
Table 90. Pandemic Influenza Vaccine Market Restraints
Table 91. Global Pandemic Influenza Vaccine Sales Forecast by Type (2022-2027) & (K Doses)
Table 92. Global Pandemic Influenza Vaccine Sales Market Share Forecast by Type (2022-2027)
Table 93. Global Pandemic Influenza Vaccine Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 94. Global Pandemic Influenza Vaccine Revenue Market Share Forecast by Type (2022-2027)
Table 95. Global Pandemic Influenza Vaccine Sales Forecast by Application (2022-2027) & (K Doses)
Table 96. Global Pandemic Influenza Vaccine Sales Market Share Forecast by Application (2022-2027)
Table 97. Global Pandemic Influenza Vaccine Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 98. Global Pandemic Influenza Vaccine Revenue Market Share Forecast by Application (2022-2027)
Table 99. Global Pandemic Influenza Vaccine Sales Forecast by Region (2022-2027) & (K Doses)
Table 100. Global Pandemic Influenza Vaccine Sales Market Share Forecast by Region (2022-2027)
Table 101. Global Pandemic Influenza Vaccine Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 102. Global Pandemic Influenza Vaccine Revenue Market Share Forecast by Region (2022-2027)
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Pandemic Influenza Vaccine
Figure 2. Global Pandemic Influenza Vaccine Market Share by Type in 2020 & 2027
Figure 3. Whole Virus Vaccines Product Picture
Figure 4. Split Virus Vaccines Product Picture
Figure 5. Subunit Vaccines Product Picture
Figure 6. Global Pandemic Influenza Vaccine Market Share by Application in 2020 & 2027
Figure 7. For Children (6 months to 3 years)
Figure 8. For Adults and Children over 3 years
Figure 9. Global Pandemic Influenza Vaccine Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Pandemic Influenza Vaccine Market Size 2016-2027 (US$ Million)
Figure 11. Global Pandemic Influenza Vaccine Sales 2016-2027 (K Doses)
Figure 12. Global Pandemic Influenza Vaccine Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 13. Pandemic Influenza Vaccine Sales Share by Manufacturers in 2020
Figure 14. Global Pandemic Influenza Vaccine Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Pandemic Influenza Vaccine Players: Market Share by Revenue in 2020
Figure 16. Pandemic Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global Pandemic Influenza Vaccine Sales Market Share by Region (2016-2021)
Figure 18. Global Pandemic Influenza Vaccine Sales Market Share by Region in 2020
Figure 19. Global Pandemic Influenza Vaccine Revenue Market Share by Region (2016-2021)
Figure 20. Global Pandemic Influenza Vaccine Revenue Market Share by Region in 2020
Figure 21. U.S. Pandemic Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada Pandemic Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Germany Pandemic Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. France Pandemic Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. U.K. Pandemic Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Italy Pandemic Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Russia Pandemic Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. China Pandemic Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Japan Pandemic Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. South Korea Pandemic Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. India Pandemic Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Australia Pandemic Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Taiwan Pandemic Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Indonesia Pandemic Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Thailand Pandemic Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Malaysia Pandemic Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Philippines Pandemic Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Vietnam Pandemic Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Mexico Pandemic Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Brazil Pandemic Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Argentina Pandemic Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Turkey Pandemic Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Saudi Arabia Pandemic Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. U.A.E Pandemic Influenza Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Sales Market Share of Pandemic Influenza Vaccine by Type (2016-2021)
Figure 46. Sales Market Share of Pandemic Influenza Vaccine by Application (2016-2021)
Figure 47. Sales Market Share of Pandemic Influenza Vaccine by Application in 2020
Figure 48. Revenue Share of Pandemic Influenza Vaccine by Application (2016-2021)
Figure 49. Revenue Share of Pandemic Influenza Vaccine by Application in 2020
Figure 50. Manufacturing Cost Structure of Pandemic Influenza Vaccine
Figure 51. Manufacturing Process Analysis of Pandemic Influenza Vaccine
Figure 52. Pandemic Influenza Vaccine Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed